Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription Articles published in BMC Cancer Retrieve available abstracts of 137 articles: HTML format Text format

Single Articles

November 2018
1. TIAN Y, Li J, Zhou T, Tong D, et al
   Spatially varying effects of predictors for the survival prediction of nonmetastatic colorectal Cancer.
   BMC Cancer. 2018;18:1084.
   PubMed     Text format     Abstract available
   
   
   
2. MAHMOOD S, English DR, MacInnis RJ, Karahalios A, et al
   Domain-specific physical activity and the risk of colorectal cancer: results from the Melbourne Collaborative Cohort Study.
   BMC Cancer. 2018;18:1063.
   PubMed     Text format     Abstract available
   
   
   
3. LEE CH, Im EJ, Moon PG, Baek MC, et al
   Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles.
   BMC Cancer. 2018;18:1058.
   PubMed     Text format     Abstract available
   
   
   
4. CRUZ-NOVA P, Schnoor M, Correa-Basurto J, Bello M, et al
   The small organic molecule C19 binds and strengthens the KRAS4b-PDEdelta complex and inhibits growth of colorectal cancer cells in vitro and in vivo.
   BMC Cancer. 2018;18:1056.
   PubMed     Text format     Abstract available
   
   
   October 2018
5. KAERLEV L, Iachina M, Trosko O, Qvist N, et al
   Colon cancer patients with a serious psychiatric disorder present with a more advanced cancer stage and receive less adjuvant chemotherapy - A Nationwide Danish Cohort Study.
   BMC Cancer. 2018;18:1050.
   PubMed     Text format     Abstract available
   
   
   
6. YE X, Mo M, Xu S, Yang Q, et al
   The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.
   BMC Cancer. 2018;18:1023.
   PubMed     Text format     Abstract available
   
   
   
7. O'GORMAN C, Stack J, O'Ceilleachair A, Denieffe S, et al
   Colorectal cancer survivors: an investigation of symptom burden and influencing factors.
   BMC Cancer. 2018;18:1022.
   PubMed     Text format     Abstract available
   
   
   
8. ZENG Z, Yang H, Xiao S
   ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer.
   BMC Cancer. 2018;18:1020.
   PubMed     Text format     Abstract available
   
   
   
9. PERTTULA K, Schiffman C, Edmands WMB, Petrick L, et al
   Untargeted lipidomic features associated with colorectal cancer in a prospective cohort.
   BMC Cancer. 2018;18:996.
   PubMed     Text format     Abstract available
   
   
   
10. SPERLICH A, Balmert A, Doll D, Bauer S, et al
    Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer.
    BMC Cancer. 2018;18:998.
    PubMed     Text format     Abstract available
    
    
    
11. SHIGEMATSU Y, Inamura K, Yamamoto N, Mise Y, et al
    Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.
    BMC Cancer. 2018;18:980.
    PubMed     Text format     Abstract available
    
    
    
12. WANG X, Zamdborg L, Ye H, Grills IS, et al
    A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer.
    BMC Cancer. 2018;18:962.
    PubMed     Text format     Abstract available
    
    
    
13. SHI J, Fei J, Yi Q, Shen L, et al
    Treatment of colon cancer in a patient with systemic lupus erythematosus: a case report.
    BMC Cancer. 2018;18:961.
    PubMed     Text format     Abstract available
    
    
    
14. DOTE S, Itakura S, Kamei K, Hira D, et al
    Oral mucositis associated with anti-EGFR therapy in colorectal cancer: single institutional retrospective cohort study.
    BMC Cancer. 2018;18:957.
    PubMed     Text format     Abstract available
    
    
    
15. MIZOTA Y, Kanemitsu Y, Tsukamoto S, Shida D, et al
    ROK study-C (Rainbow of KIBOU study-colorectum): a colorectal cancer survivor cohort study on food, nutrition, physical activity, psychosocial factors and its influences on colorectal cancer recurrence, survival and quality of life in Japan.
    BMC Cancer. 2018;18:953.
    PubMed     Text format     Abstract available
    
    
    
16. CANTERO-CID R, Casas-Martin J, Hernandez-Jimenez E, Cubillos-Zapata C, et al
    PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
    BMC Cancer. 2018;18:945.
    PubMed     Text format     Abstract available
    
    
    September 2018
17. YANG L, Xiong Z, Xie QK, He W, et al
    Second primary colorectal cancer after the initial primary colorectal cancer.
    BMC Cancer. 2018;18:931.
    PubMed     Text format     Abstract available
    
    
    
18. WHITE A, Ironmonger L, Steele RJC, Ormiston-Smith N, et al
    A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK.
    BMC Cancer. 2018;18:906.
    PubMed     Text format     Abstract available
    
    
    
19. SEIDENSTICKER R, Damm R, Enge J, Seidensticker M, et al
    Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival.
    BMC Cancer. 2018;18:882.
    PubMed     Text format     Abstract available
    
    
    
20. SCHLIEMANN D, Donnelly M, Dahlui M, Loh SY, et al
    The 'Be Cancer Alert Campaign': protocol to evaluate a mass media campaign to raise awareness about breast and colorectal cancer in Malaysia.
    BMC Cancer. 2018;18:881.
    PubMed     Text format     Abstract available
    
    
    
21. HO V, Chung L, Singh A, Lea V, et al
    Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis.
    BMC Cancer. 2018;18:869.
    PubMed     Text format     Abstract available
    
    
    August 2018
22. DURINIKOVA E, Kozovska Z, Poturnajova M, Plava J, et al
    ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells.
    BMC Cancer. 2018;18:848.
    PubMed     Text format     Abstract available
    
    
    
23. LUALDI M, Cavalleri A, Battaglia L, Colombo A, et al
    Early detection of colorectal adenocarcinoma: a clinical decision support tool based on plasma porphyrin accumulation and risk factors.
    BMC Cancer. 2018;18:841.
    PubMed     Text format     Abstract available
    
    
    
24. SUN X, Ju T, Cummings RD
    Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.
    BMC Cancer. 2018;18:827.
    PubMed     Text format     Abstract available
    
    
    
25. SABER MM, Al-Mahallawi AM, Nassar NN, Stork B, et al
    Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes.
    BMC Cancer. 2018;18:822.
    PubMed     Text format     Abstract available
    
    
    
26. PUIJK RS, Ruarus AH, Vroomen LGPH, van Tilborg AAJM, et al
    Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial.
    BMC Cancer. 2018;18:821.
    PubMed     Text format     Abstract available
    
    
    
27. RUDERMAN S, Eshein A, Valuckaite V, Dougherty U, et al
    Early increase in blood supply (EIBS) is associated with tumor risk in the Azoxymethane model of colon cancer.
    BMC Cancer. 2018;18:814.
    PubMed     Text format     Abstract available
    
    
    
28. TOSI D, Perez-Gracia E, Atis S, Vie N, et al
    Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatment.
    BMC Cancer. 2018;18:812.
    PubMed     Text format     Abstract available
    
    
    
29. LAN L, Liu H, Smith AR, Appelman C, et al
    Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins.
    BMC Cancer. 2018;18:809.
    PubMed     Text format     Abstract available
    
    
    
30. REDMOND HP, Neary PM, Jinih M, O'Connell E, et al
    RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.A.N.T. trial.
    BMC Cancer. 2018;18:794.
    PubMed     Text format     Abstract available
    
    
    
31. LI N, Chen M, Cao Y, Li H, et al
    Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.
    BMC Cancer. 2018;18:793.
    PubMed     Text format     Abstract available
    
    
    July 2018
32. CHIU KWH, Lam KO, An H, Cheung GTC, et al
    Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis.
    BMC Cancer. 2018;18:776.
    PubMed     Text format     Abstract available
    
    
    
33. MOGENSEN MB, Rossing M, Ostrup O, Larsen PN, et al
    Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.
    BMC Cancer. 2018;18:752.
    PubMed     Text format     Abstract available
    
    
    
34. LEERMAKERS L, Doking S, Thewes B, Braamse AMJ, et al
    Study protocol of the CORRECT multicenter trial: the efficacy of blended cognitive behavioral therapy for reducing psychological distress in colorectal cancer survivors.
    BMC Cancer. 2018;18:748.
    PubMed     Text format     Abstract available
    
    
    
35. TIKK K, Weigl K, Hoffmeister M, Igel S, et al
    Study protocol of the RaPS study: novel risk adapted prevention strategies for people with a family history of colorectal cancer.
    BMC Cancer. 2018;18:720.
    PubMed     Text format     Abstract available
    
    
    June 2018
36. MOLNAR B, Galamb O, Peterfia B, Wichmann B, et al
    Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
    BMC Cancer. 2018;18:695.
    PubMed     Text format     Abstract available
    
    
    
37. CRESPO A, Garcia-Suarez O, Fernandez-Vega I, Solis-Hernandez MP, et al
    Heparan sulfate proteoglycans undergo differential expression alterations in left sided colorectal cancer, depending on their metastatic character.
    BMC Cancer. 2018;18:687.
    PubMed     Text format     Abstract available
    
    
    
38. BOCKELMAN C, Beilmann-Lehtonen I, Kaprio T, Koskensalo S, et al
    Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
    BMC Cancer. 2018;18:679.
    PubMed     Text format     Abstract available
    
    
    
39. NEILSEN BK, Chakraborty B, McCall JL, Frodyma DE, et al
    WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage.
    BMC Cancer. 2018;18:673.
    PubMed     Text format     Abstract available
    
    
    
40. KOZOVSKA Z, Patsalias A, Bajzik V, Durinikova E, et al
    ALDH1A inhibition sensitizes colon cancer cells to chemotherapy.
    BMC Cancer. 2018;18:656.
    PubMed     Text format     Abstract available
    
    
    
41. PANATO C, Abusamaan K, Bidoli E, Hamdi-Cherif M, et al
    Survival after the diagnosis of breast or colorectal cancer in the GAZA Strip from 2005 to 2014.
    BMC Cancer. 2018;18:632.
    PubMed     Text format     Abstract available
    
    
    
42. GUAN X, Wang Y, Hu H, Zhao Z, et al
    Reconsideration of the optimal minimum lymph node count for young colon cancer patients: a population-based study.
    BMC Cancer. 2018;18:623.
    PubMed     Text format     Abstract available
    
    
    May 2018
43. GONG X, Chen Z, Han Q, Chen C, et al
    Sanguinarine triggers intrinsic apoptosis to suppress colorectal cancer growth through disassociation between STRAP and MELK.
    BMC Cancer. 2018;18:578.
    PubMed     Text format     Abstract available
    
    
    
44. YANG L, Xiong Z, Xie Q, He W, et al
    Prognostic value of total number of lymph nodes retrieved differs between left-sided colon cancer and right-sided colon cancer in stage III patients with colon cancer.
    BMC Cancer. 2018;18:558.
    PubMed     Text format     Abstract available
    
    
    
45. SHULDINER J, Liu Y, Lofters A
    Incidence of breast and colorectal cancer among immigrants in Ontario, Canada: a retrospective cohort study from 2004-2014.
    BMC Cancer. 2018;18:537.
    PubMed     Text format     Abstract available
    
    
    
46. RUHL R, Rana S, Kelley K, Espinosa-Diez C, et al
    microRNA-451a regulates colorectal cancer proliferation in response to radiation.
    BMC Cancer. 2018;18:517.
    PubMed     Text format     Abstract available
    
    
    April 2018
47. MEI Z, Shao YW, Lin P, Cai X, et al
    SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients.
    BMC Cancer. 2018;18:479.
    PubMed     Text format     Abstract available
    
    
    
48. FORSTER I, Brockmann M, Schildgen O, Schildgen V, et al
    Microsatellite instability testing in colorectal cancer using the QiaXcel advanced platform.
    BMC Cancer. 2018;18:484.
    PubMed     Text format     Abstract available
    
    
    
49. HEALY MA, Morris AM, Abrahamse P, Ward KC, et al
    The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program.
    BMC Cancer. 2018;18:481.
    PubMed     Text format     Abstract available
    
    
    
50. BRONZWAER MES, Greuter MJE, Bleijenberg AGC, IJspeert JEG, et al
    Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening.
    BMC Cancer. 2018;18:465.
    PubMed     Text format     Abstract available
    
    
    
51. ARROSPIDE A, Idigoras I, Mar J, de Koning H, et al
    Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model.
    BMC Cancer. 2018;18:464.
    PubMed     Text format     Abstract available
    
    
    
52. MUNKER S, Gerken M, Fest P, Ott C, et al
    Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects.
    BMC Cancer. 2018;18:455.
    PubMed     Text format     Abstract available
    
    
    
53. MENG H, Li W, Boardman LA, Wang L, et al
    Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
    BMC Cancer. 2018;18:433.
    PubMed     Text format     Abstract available
    
    
    
54. FANG HJ, Shan SB, Zhou YH, Zhong LY, et al
    Diabetes mellitus and the risk of gastrointestinal cancer in women compared with men: a meta-analysis of cohort studies.
    BMC Cancer. 2018;18:422.
    PubMed     Text format     Abstract available
    
    
    
55. SHINOZAKI E, Tanabe K, Akiyoshi T, Tsuchida T, et al
    Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker.
    BMC Cancer. 2018;18:406.
    PubMed     Text format     Abstract available
    
    
    
56. SORIANO LC, Soriano-Gabarro M, Garcia Rodriguez LA
    Trends in the contemporary incidence of colorectal cancer and patient characteristics in the United Kingdom: a population-based cohort study using The Health Improvement Network.
    BMC Cancer. 2018;18:402.
    PubMed     Text format     Abstract available
    
    
    
57. WANG H, Chen X, Liu H, Mou T, et al
    Laparoscopy-assisted colectomy as an Oncologically safe alternative for patients with stage T4 Colon Cancer: a propensity-matched cohort study.
    BMC Cancer. 2018;18:370.
    PubMed     Text format     Abstract available
    
    
    
58. SHIBUTANI M, Maeda K, Nagahara H, Fukuoka T, et al
    A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
    BMC Cancer. 2018;18:371.
    PubMed     Text format     Abstract available
    
    
    
59. SHIN HY, Suh M, Choi KS, Hwang SH, et al
    Higher satisfaction with an alternative collection device for stool sampling in colorectal cancer screening with fecal immunochemical test: a cross-sectional study.
    BMC Cancer. 2018;18:365.
    PubMed     Text format     Abstract available
    
    
    
60. SHEN MH, Chen LP, Ho TF, Shih YY, et al
    Validation of the Taiwan Chinese version of the EORTC QLQ-CR29 to assess quality of life in colorectal cancer patients.
    BMC Cancer. 2018;18:353.
    PubMed     Text format     Abstract available
    
    
    March 2018
61. SHIDA D, Ahiko Y, Tanabe T, Yoshida T, et al
    Shorter survival in adolescent and young adult patients, compared to adult patients, with stage IV colorectal cancer in Japan.
    BMC Cancer. 2018;18:334.
    PubMed     Text format     Abstract available
    
    
    
62. HAMASHIMA C, Sano H
    Association between age factors and strategies for promoting participation in gastric and colorectal cancer screenings.
    BMC Cancer. 2018;18:345.
    PubMed     Text format     Abstract available
    
    
    
63. YOUNG JM, Durcinoska I, DeLoyde K, Solomon MJ, et al
    Patterns of follow up and survivorship care for people with colorectal cancer in new South Wales, Australia: a population-based survey.
    BMC Cancer. 2018;18:339.
    PubMed     Text format     Abstract available
    
    
    
64. HUANG EY, Chang JC, Chen HH, Hsu CY, et al
    Carcinoembryonic antigen as a marker of radioresistance in colorectal cancer: a potential role of macrophages.
    BMC Cancer. 2018;18:321.
    PubMed     Text format     Abstract available
    
    
    
65. BUROCK S, Daum S, Keilholz U, Neumann K, et al
    Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial.
    BMC Cancer. 2018;18:297.
    PubMed     Text format     Abstract available
    
    
    
66. TAI LH, Ananth AA, Seth R, Alkayyal A, et al
    Sepsis increases perioperative metastases in a murine model.
    BMC Cancer. 2018;18:277.
    PubMed     Text format     Abstract available
    
    
    
67. GAO P, Huang XZ, Song YX, Sun JX, et al
    Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study.
    BMC Cancer. 2018;18:234.
    PubMed     Text format     Abstract available
    
    
    
68. EL KINANY K, Deoula M, Hatime Z, Bennani B, et al
    Dairy products and colorectal cancer in middle eastern and north African countries: a systematic review.
    BMC Cancer. 2018;18:233.
    PubMed     Text format     Abstract available
    
    
    February 2018
69. GRAY RT, Coleman HG, Hughes C, Murray LJ, et al
    Low-dose aspirin use and survival in colorectal cancer: results from a population-based cohort study.
    BMC Cancer. 2018;18:228.
    PubMed     Text format     Abstract available
    
    
    
70. STRAINIENE E, Binkis M, Urnikyte S, Stankevicius V, et al
    Microenvironment dependent gene expression signatures in reprogrammed human colon normal and cancer cell lines.
    BMC Cancer. 2018;18:222.
    PubMed     Text format     Abstract available
    
    
    
71. KOWALCZYK M, Orlowski M, Siermontowski P, Mucha D, et al
    Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients.
    BMC Cancer. 2018;18:213.
    PubMed     Text format     Abstract available
    
    
    
72. WANG T, Ning K, Sun X, Zhang C, et al
    Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
    BMC Cancer. 2018;18:207.
    PubMed     Text format     Abstract available
    
    
    
73. HEUBLEIN S, Albertsmeier M, Pfeifer D, Loehrs L, et al
    Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer.
    BMC Cancer. 2018;18:201.
    PubMed     Text format     Abstract available
    
    
    
74. ARJONA-SANCHEZ A, Barrios P, Boldo-Roda E, Camps B, et al
    HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma.
    BMC Cancer. 2018;18:183.
    PubMed     Text format     Abstract available
    
    
    
75. ZHU Y, Wang PP, Zhai G, Bapat B, et al
    Association of rs2282679 A>C polymorphism in vitamin D binding protein gene with colorectal cancer risk and survival: effect modification by dietary vitamin D intake.
    BMC Cancer. 2018;18:155.
    PubMed     Text format     Abstract available
    
    
    
76. RICHTER J, Kretz AL, Lemke J, Fauler M, et al
    CK1alpha overexpression correlates with poor survival in colorectal cancer.
    BMC Cancer. 2018;18:140.
    PubMed     Text format     Abstract available
    
    
    
77. MARTINEZ-USEROS J, Moreno I, Fernandez-Acenero MJ, Rodriguez-Remirez M, et al
    The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    BMC Cancer. 2018;18:144.
    PubMed     Text format     Abstract available
    
    
    
78. KLAUCK PJ, Bagby SM, Capasso A, Bradshaw-Pierce EL, et al
    Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer.
    BMC Cancer. 2018;18:136.
    PubMed     Text format     Abstract available
    
    
    
79. OZAKI Y, Shindoh J, Gonoi W, Nishioka Y, et al
    Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: retrospective pilot study.
    BMC Cancer. 2018;18:138.
    PubMed     Text format     Abstract available
    
    
    January 2018
80. BATTAGLIN F, Schirripa M, Buggin F, Pietrantonio F, et al
    The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients.
    BMC Cancer. 2018;18:98.
    PubMed     Text format     Abstract available
    
    
    
81. BUSCH EL, Don PK, Chu H, Richardson DB, et al
    Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors.
    BMC Cancer. 2018;18:82.
    PubMed     Text format     Abstract available
    
    
    
82. ENGSTRAND J, Nilsson H, Stromberg C, Jonas E, et al
    Colorectal cancer liver metastases - a population-based study on incidence, management and survival.
    BMC Cancer. 2018;18:78.
    PubMed     Text format     Abstract available
    
    
    
83. WANG X, Chen J, Wang J, Yu F, et al
    Correction to: Metalloproteases meprin-a (MEP1A) is a prognostic biomarker and promotes proliferation and invasion of colorectal cancer.
    BMC Cancer. 2018;18:70.
    PubMed     Text format     Abstract available
    
    
    
84. SHAW E, Farris MS, Stone CR, Derksen JWG, et al
    Effects of physical activity on colorectal cancer risk among family history and body mass index subgroups: a systematic review and meta-analysis.
    BMC Cancer. 2018;18:71.
    PubMed     Text format     Abstract available
    
    
    
85. KONG X, Li J, Cai Y, Tian Y, et al
    A modified TNM staging system for non-metastatic colorectal cancer based on nomogram analysis of SEER database.
    BMC Cancer. 2018;18:50.
    PubMed     Text format     Abstract available
    
    
    
86. DAVIS MM, Freeman M, Shannon J, Coronado GD, et al
    A systematic review of clinic and community intervention to increase fecal testing for colorectal cancer in rural and low-income populations in the United States - How, what and when?
    BMC Cancer. 2018;18:40.
    PubMed     Text format     Abstract available
    
    
    
87. HERNANDEZ RK, Wade SW, Reich A, Pirolli M, et al
    Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States.
    BMC Cancer. 2018;18:44.
    PubMed     Text format     Abstract available
    
    
    
88. GU MJ, Huang QC, Bao CZ, Li YJ, et al
    Attributable causes of colorectal cancer in China.
    BMC Cancer. 2018;18:38.
    PubMed     Text format     Abstract available
    
    
    
89. FENNELL LJ, Jamieson S, McKeone D, Corish T, et al
    MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF(V600E) mutation.
    BMC Cancer. 2018;18:35.
    PubMed     Text format     Abstract available
    
    
    
90. DEPCZYNSKI J, Dobbins T, Armstrong B, Lower T, et al
    Comparison of cancer incidence in Australian farm residents 45 years and over, compared to rural non-farm and urban residents - a data linkage study.
    BMC Cancer. 2018;18:33.
    PubMed     Text format     Abstract available
    
    
    
91. FARSHIDFAR F, Kopciuk KA, Hilsden R, McGregor SE, et al
    A quantitative multimodal metabolomic assay for colorectal cancer.
    BMC Cancer. 2018;18:26.
    PubMed     Text format     Abstract available
    
    
    
92. ARAKAWA K, Hata K, Yamamoto Y, Nishikawa T, et al
    Nine primary malignant neoplasms-involving the esophagus, stomach, colon, rectum, prostate, and external ear canal-without microsatellite instability: a case report.
    BMC Cancer. 2018;18:24.
    PubMed     Text format     Abstract available
    
    
    
93. HUEMER F, Thaler J, Piringer G, Hackl H, et al
    Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentose Tumortherapie).
    BMC Cancer. 2018;18:11.
    PubMed     Text format     Abstract available
    
    
    December 2017
94. ZHANG K, Wang Y, Yu X, Shi Y, et al
    Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth.
    BMC Cancer. 2017;17:899.
    PubMed     Text format     Abstract available
    
    
    
95. FALKOWSKI S, Woillard JB, Postil D, Tubiana-Mathieu N, et al
    Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study.
    BMC Cancer. 2017;17:901.
    PubMed     Text format     Abstract available
    
    
    
96. SONG N, Shin A, Jung HS, Oh JH, et al
    Effects of interactions between common genetic variants and smoking on colorectal cancer.
    BMC Cancer. 2017;17:869.
    PubMed     Text format     Abstract available
    
    
    
97. SHIN HY, Suh M, Park B, Jun JK, et al
    Perceptions of colorectal cancer screening and recommendation behaviors among physicians in Korea.
    BMC Cancer. 2017;17:860.
    PubMed     Text format     Abstract available
    
    
    
98. YEH YS, Chang YT, Ma CJ, Huang CW, et al
    First-decade patient with colorectal cancer carrying both germline and somatic mutations in APC gene.
    BMC Cancer. 2017;17:849.
    PubMed     Text format     Abstract available
    
    
    
99. CAO B, Luo L, Feng L, Ma S, et al
    A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.
    BMC Cancer. 2017;17:844.
    PubMed     Text format     Abstract available
    
    
    
100. BEEBE-DIMMER JL, Yee C, Paskett E, Schwartz AG, et al
     Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women's health initiative.
     BMC Cancer. 2017;17:848.
     PubMed     Text format     Abstract available
     
     
     
101. LEE J, Xiao YY, Sun YY, Balderacchi J, et al
     Prevalence and characteristics of hereditary non-polyposis colorectal cancer (HNPCC) syndrome in immigrant Asian colorectal cancer patients.
     BMC Cancer. 2017;17:843.
     PubMed     Text format     Abstract available
     
     
     
102. VULCAN A, Manjer J, Ohlsson B
     High blood glucose levels are associated with higher risk of colon cancer in men: a cohort study.
     BMC Cancer. 2017;17:842.
     PubMed     Text format     Abstract available
     
     
     
103. COELHO H, Jones-Hughes T, Snowsill T, Briscoe S, et al
     A systematic review of test accuracy studies evaluating molecular micro-satellite instability testing for the detection of individuals with lynch syndrome.
     BMC Cancer. 2017;17:836.
     PubMed     Text format     Abstract available
     
     
     
104. BENEDICTO A, Marquez J, Herrero A, Olaso E, et al
     Decreased expression of the beta2 integrin on tumor cells is associated with a reduction in liver metastasis of colorectal cancer in mice.
     BMC Cancer. 2017;17:827.
     PubMed     Text format     Abstract available
     
     
     
105. ZHOU P, Wang C, Hu Z, Chen W, et al
     Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-kappaB/slug/E-cadherin pathway.
     BMC Cancer. 2017;17:813.
     PubMed     Text format     Abstract available
     
     
     November 2017
106. HAN VAN KRIEKEN J, Kafatos G, Bennett J, Mineur L, et al
     Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review.
     BMC Cancer. 2017;17:798.
     PubMed     Text format     Abstract available
     
     
     
107. YANG J, Du XL, Li S, Wu Y, et al
     The risk and survival outcome of subsequent primary colorectal cancer after the first primary colorectal cancer: cases from 1973 to 2012.
     BMC Cancer. 2017;17:783.
     PubMed     Text format     Abstract available
     
     
     
108. THIEBAULT Q, Defossez G, Karayan-Tapon L, Ingrand P, et al
     Analysis of factors influencing molecular testing at diagnostic of colorectal cancer.
     BMC Cancer. 2017;17:765.
     PubMed     Text format     Abstract available
     
     
     
109. STEVANATO FILHO PR, Aguiar Junior S, Begnami MD, Kuasne H, et al
     Oestrogen receptor beta isoform expression in sporadic colorectal cancer, familial adenomatous polyposis and progressive stages of colorectal cancer.
     BMC Cancer. 2017;17:754.
     PubMed     Text format     Abstract available
     
     
     
110. SONG Y, Yang Y, Gao P, Chen X, et al
     The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
     BMC Cancer. 2017;17:744.
     PubMed     Text format     Abstract available
     
     
     
111. ALONSO-MOLERO J, Gonzalez-Donquiles C, Fernandez-Villa T, de Souza-Teixeira F, et al
     Alterations in PGC1alpha expression levels are involved in colorectal cancer risk: a qualitative systematic review.
     BMC Cancer. 2017;17:731.
     PubMed     Text format     Abstract available
     
     
     
112. ERNST J, Mehnert A, Dietz A, Hornemann B, et al
     Perceived stigmatization and its impact on quality of life - results from a large register-based study including breast, colon, prostate and lung cancer patients.
     BMC Cancer. 2017;17:741.
     PubMed     Text format     Abstract available
     
     
     
113. TAKAHASHI H, Takahashi M, Ohnuma S, Unno M, et al
     microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer.
     BMC Cancer. 2017;17:723.
     PubMed     Text format     Abstract available
     
     
     
114. YANG C, Zou K, Zheng L, Xiong B, et al
     Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
     BMC Cancer. 2017;17:725.
     PubMed     Text format     Abstract available
     
     
     
115. YU X, Mi L, Dong J, Zou J, et al
     Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a "sponge" against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells.
     BMC Cancer. 2017;17:716.
     PubMed     Text format     Abstract available
     
     
     October 2017
116. STEVENS JR, Herrick JS, Wolff RK, Slattery ML, et al
     Identifying factors associated with the direction and significance of microRNA tumor-normal expression differences in colorectal cancer.
     BMC Cancer. 2017;17:707.
     PubMed     Text format     Abstract available
     
     
     
117. RATJEN I, Schafmayer C, di Giuseppe R, Waniek S, et al
     Postdiagnostic physical activity, sleep duration, and TV watching and all-cause mortality among long-term colorectal cancer survivors: a prospective cohort study.
     BMC Cancer. 2017;17:701.
     PubMed     Text format     Abstract available
     
     
     
118. UNGARI AQ, Pereira LRL, Nunes AA, Peria FM, et al
     Cost-effectiveness analysis of XELOX versus XELOX plus bevacizumab for metastatic colorectal cancer in a public hospital school.
     BMC Cancer. 2017;17:691.
     PubMed     Text format     Abstract available
     
     
     August 2017
119. PARK SM, Lee J, Kim YA, Chang YJ, et al
     Factors related with colorectal and stomach cancer screening practice among disease-free lung cancer survivors in Korea.
     BMC Cancer. 2017;17:600.
     PubMed     Text format     Abstract available
     
     
     June 2017
120. COEN M, Rigamonti F, Roth A, Koessler T, et al
     Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature.
     BMC Cancer. 2017;17:394.
     PubMed     Text format     Abstract available
     
     
     May 2017
121. DARWANTO A, Hein AM, Strauss S, Kong Y, et al
     Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform.
     BMC Cancer. 2017;17:358.
     PubMed     Text format     Abstract available
     
     
     
122. DE FELICE F, Benevento I, Magnante AL, Musio D, et al
     Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer.
     BMC Cancer. 2017;17:325.
     PubMed     Text format     Abstract available
     
     
     April 2017
123. LELONG B, de Chaisemartin C, Meillat H, Cournier S, et al
     A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design.
     BMC Cancer. 2017;17:253.
     PubMed     Text format     Abstract available
     
     
     March 2017
124. LI X, Lu H, Xu K, Wang H, et al
     Negative lymph node count is an independent prognostic factor for patients with rectal cancer who received preoperative radiotherapy.
     BMC Cancer. 2017;17:227.
     PubMed     Text format     Abstract available
     
     
     
125. BERNTSEN S, Aaronson NK, Buffart L, Borjeson S, et al
     Design of a randomized controlled trial of physical training and cancer (Phys-Can) - the impact of exercise intensity on cancer related fatigue, quality of life and disease outcome.
     BMC Cancer. 2017;17:218.
     PubMed     Text format     Abstract available
     
     
     
126. CERVANTES-MADRID D, Wettergren Y, Falk P, Lundholm K, et al
     DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies.
     BMC Cancer. 2017;17:219.
     PubMed     Text format     Abstract available
     
     
     
127. FENG YR, Jin J, Ren H, Wang X, et al
     Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rate.
     BMC Cancer. 2017;17:182.
     PubMed     Text format     Abstract available
     
     
     
128. FORZATI F, De Martino M, Esposito F, Sepe R, et al
     miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene.
     BMC Cancer. 2017;17:170.
     PubMed     Text format     Abstract available
     
     
     February 2017
129. BRUNET J, Burke S, Grocott MP, West MA, et al
     The effects of exercise on pain, fatigue, insomnia, and health perceptions in patients with operable advanced stage rectal cancer prior to surgery: a pilot trial.
     BMC Cancer. 2017;17:153.
     PubMed     Text format     Abstract available
     
     
     
130. SINGH VP, Katta S, Kumar S
     WD-repeat protein WDR13 is a novel transcriptional regulator of c-Jun and modulates intestinal homeostasis in mice.
     BMC Cancer. 2017;17:148.
     PubMed     Text format     Abstract available
     
     
     
131. WEYN C, Van Raemdonck S, Dendooven R, Maes V, et al
     Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples.
     BMC Cancer. 2017;17:139.
     PubMed     Text format     Abstract available
     
     
     
132. PAHLE J, Menzel L, Niesler N, Kobelt D, et al
     Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.
     BMC Cancer. 2017;17:129.
     PubMed     Text format     Abstract available
     
     
     
133. MEDENWALD D, Vordermark D, Dietzel CT
     Cancer mortality in former East and West Germany: a story of unification?
     BMC Cancer. 2017;17:94.
     PubMed     Text format     Abstract available
     
     
     January 2017
134. STEVENSON HL, Prats MM, Sasatomi E
     Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis.
     BMC Cancer. 2017;17:35.
     PubMed     Text format     Abstract available
     
     
     December 2016
135. YEDID N, Kalma Y, Malcov M, Amit A, et al
     The effect of a germline mutation in the APC gene on beta-catenin in human embryonic stem cells.
     BMC Cancer. 2016;16:952.
     PubMed     Text format     Abstract available
     
     
     November 2016
136. ZHANG J, Ren J, Wei J, Chong CC, et al
     Alternative splicing of estrogen receptor alpha in hepatocellular carcinoma.
     BMC Cancer. 2016;16:926.
     PubMed     Text format     Abstract available
     
     
     
137. STEPPELER C, Sodring M, Paulsen JE
     Colorectal Carcinogenesis in the A/J Min/+ Mouse Model is Inhibited by Hemin, Independently of Dietary Fat Content and Fecal Lipid Peroxidation Rate.
     BMC Cancer. 2016;16:832.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: